Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Next-generation sequencing reveals clinically actionable molecular markers in myeloid sarcoma

19 Mar 2015

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Acute Myeloid Leukemia Research
Share to Histone Deacetylase Inhibitors Research
Share to Vascular Tumors and Angiosarcomas

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 25787914
DOI: 10.1038/leu.2015.81

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Next-generation sequencing reveals clinically actionable molecular markers in myeloid sarcomaPMID 25787914Read ↗

A novel next generation sequencing approach to improve sarcoma diagnosisSemantic proximity Read ↗

Detection of prognostically relevant mutations and translocations in myeloid sarcoma by next generation sequencingSemantic proximity Read ↗

Genomic Profiling of Sarcomas: A Promising Weapon in the Therapeutic ArsenalSemantic proximity Read ↗

Molecular findings in myeloid neoplasms.Semantic proximity Read ↗

The role of next-generation sequencing in hematologic malignanciesSemantic proximity Read ↗

Multiomic characterization, early detection, and therapeutic targeting of myeloid sarcomaSemantic proximity Read ↗

Lessons from next-generation sequencing analysis in hematological malignanciesSemantic proximity Read ↗

Diagnostic, Prognostic, and Predictive Utility of Recurrent Somatic Mutations in Myeloid Neoplasms.Semantic proximity Read ↗

Molecular Pathology: Prognostic and Diagnostic Genomic Markers for Myeloid Neoplasms.Semantic proximity Read ↗

Molecular genetic biomarkers in myeloid malignancies.Semantic proximity Read ↗

Clinical genomic profiling in the management of patients with soft tissue and bone sarcoma.Semantic proximity Read ↗

Gene Mutations and Targeted Therapies of Myeloid Sarcoma.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.